NCT04725630

Brief Summary

It is important for individuals with type 2 diabetes (T2DM) to adhere to a healthy dietary pattern to maintain optimal blood glucose levels and overall health. The increasing costs of healthy foods, however, is a barrier to maintaining healthful dietary patterns, particularly for individuals with T2DM who are experiencing food insecurity (i.e., inadequate or insecure access to food due to financial constraints). Lower diet quality may result in difficulties maintaining optimal blood glucose levels, leading to higher rates of diabetes complications, and increased acute care usage and costs. Effective strategies to address this issue are lacking despite the well-known impact of food insecurity on maintaining optimal blood glucose levels. One way to address this problem is to provide incentives to purchase healthy foods through healthy food prescription programs. These programs may help to reduce food insecurity and improve diet quality, thereby improving blood glucose control and reducing diabetes complications over time. This study will investigate the reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) of a healthy food prescription incentive program among adults who are experiencing food insecurity and persistent hyperglycemia through three concurrent studies; a randomized controlled trial, an implementation study, and a modelling study. The randomized controlled trial will examine the effectiveness of a healthy food prescription incentive program compared to a healthy food prescription alone in reducing blood glucose levels among adults who are experiencing food insecurity and persistent hyperglycemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
597

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 27, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

May 29, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 7, 2025

Completed
Last Updated

June 26, 2026

Status Verified

June 1, 2026

Enrollment Period

2.8 years

First QC Date

January 19, 2021

Last Update Submit

June 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood glucose levels via hemoglobin A1C

    Difference between intervention and comparison groups in blood glucose levels measured by hemoglobin A1C

    Assessed at Baseline (0 months) and Follow-up (6 months, 12 months, 18 months)

Secondary Outcomes (20)

  • Blood glucose levels via elevated hemoglobin A1C

    Assessed at Baseline (0 months) and Follow-up (6 months, 12 months, 18 months)

  • Blood glucose levels via fructosamine

    Assessed at Baseline (0 months) and Follow-up (6 months, 12 months, 18 months)

  • Overall diet quality by Healthy Eating Index-2015 and by Healthy Eating Food Index-2019

    Assessed twice at Baseline (0 months) and twice at Follow-up (6 months, 12 months, 18 months)

  • Diet quality sub-scores by Healthy Eating Index-2015 and by Healthy Eating Food Index-2019

    Assessed twice at Baseline (0 months) and twice at Follow-up (6 months, 12 months, 18 months)

  • Fruit and vegetable intake via skin carotenoids

    Assessed at Baseline (0 months) and Follow-up (12 months)

  • +15 more secondary outcomes

Other Outcomes (7)

  • MacArthur Scale of Subjective Social Status scores

    Assessed at Baseline (0 months) and Follow-up (12 months)

  • Work Productivity and Activity Impairment scores

    Assessed at Baseline (0 months) and Follow-up (12 months)

  • Perceived Income Adequacy

    Assessed at Baseline (0 months) and Follow-up (6 months, 12 months, 18 months)

  • +4 more other outcomes

Study Arms (2)

Subsidized Healthy Food Prescription Incentive

EXPERIMENTAL

Participants will receive a one-time healthy food prescription pamphlet from their healthcare provider and a weekly incentive of $10.50/household member to purchase healthy foods in supermarkets for 12 months. The list of incentive-eligible foods includes whole, minimally processed foods with little to no added fat, sugar or salt from all food groups.

Behavioral: Healthy food incentiveBehavioral: Healthy food prescription

Healthy Food Prescription Comparison

ACTIVE COMPARATOR

Participants will receive a one-time healthy food prescription pamphlet from their healthcare provider. The pamphlet closely mimics current standard of care for patients with diabetes in Alberta (i.e., nutrition counselling).

Behavioral: Healthy food prescription

Interventions

$10.50/week/household member for 12 months to purchase healthy foods in participating supermarkets.

Subsidized Healthy Food Prescription Incentive

A one-time healthy food prescription pamphlet

Healthy Food Prescription ComparisonSubsidized Healthy Food Prescription Incentive

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18-85 years) with type 2 diabetes (or diabetes of unknown etiology)
  • Persistent hyperglycemia (i.e. hemoglobin A1C 6.5-12%)
  • Are currently experiencing food insecurity and/or report that it is difficult/very difficult to make ends meet
  • Can communicate in English or have someone to translate

You may not qualify if:

  • A1c \<6.5% or \> 12% given the recommendation for anti-hyperglycemic treatment escalation for those with A1c\>12%
  • Reside in a facility that provides meals (e.g., shelter, long-term care, prison)
  • Exhibit signs/symptoms of metabolic decompensation (weight loss, polyuria, polydipsia)
  • Diagnosis of eating disorder(s) (e.g., anorexia nervosa, bulimia)
  • Have experienced diabetic ketoacidosis or a hyperglycemic hyperosmolar emergency in the past year
  • Experienced a hypoglycemic event in the past 3 months
  • Are trying to conceive, pregnant and/or breastfeeding
  • Are currently participating in other clinical trials
  • A household member is currently or has previously participated in this trial
  • Unwilling/unable to shop in study-affiliated supermarkets for the next 12 months
  • Plan to leave for Canada for more than 2 weeks in the next 12 months
  • Unable to complete data collection at follow-up (e.g., due to moving)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Primary Care Clinics

Various Cities, Alberta, Canada

Location

Related Publications (1)

  • Olstad DL, Beall R, Spackman E, Dunn S, Lipscombe LL, Williams K, Oster R, Scott S, Zimmermann GL, McBrien KA, Steer KJD, Chan CB, Tyminski S, Berkowitz S, Edwards AL, Saunders-Smith T, Tariq S, Popeski N, White L, Williamson T, L'Abbe M, Raine KD, Nejatinamini S, Naser A, Basualdo-Hammond C, Norris C, O'Connell P, Seidel J, Lewanczuk R, Cabaj J, Campbell DJT. Healthy food prescription incentive programme for adults with type 2 diabetes who are experiencing food insecurity: protocol for a randomised controlled trial, modelling and implementation studies. BMJ Open. 2022 Feb 15;12(2):e050006. doi: 10.1136/bmjopen-2021-050006.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes Complications

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Dana Olstad, PhD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Investigators will be blinded to group allocation during data collection.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 19, 2021

First Posted

January 27, 2021

Study Start

May 29, 2021

Primary Completion

February 28, 2024

Study Completion

March 7, 2025

Last Updated

June 26, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations